Lista de obras -

5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims

artículo científico publicado en 2008

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia

artículo científico publicado en 2002

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

artículo científico publicado en 2005

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia

artículo científico

Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects

artículo científico publicado en 2007

Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).

artículo científico publicado en 2009

Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects

artículo científico publicado en 2003

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics

artículo científico publicado en 2004

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia

artículo científico publicado en 2006

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone

artículo científico publicado en 2003

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine

artículo científico publicado en 2010

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

artículo científico publicado en 2007

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia

artículo científico publicado en 2003

Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression

artículo científico publicado en 2003

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

artículo científico publicado en 2003

Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone

artículo científico

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

artículo científico publicado en 2012

Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study

article

Atypical antipsychotic use in a state hospital inpatient adolescent population

artículo científico publicado en 2004

Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims.

artículo científico publicado en 2005

Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims

artículo científico publicado en 2008

Cardiovascular disease in relation to weight in deceased persons with schizophrenia

artículo científico publicado en 2005

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study

artículo científico publicado en 2010

Challenge to atypical antipsychotic drug effect on cognition.

artículo científico publicado en 2007

Circumstances of suicide among individuals with schizophrenia

artículo científico publicado en 2002

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

artículo científico publicado en 2003

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

artículo científico publicado en 2006

Clozapine treatment in patients with prior substance abuse

artículo científico publicado en 2003

Clozapine underutilization and discontinuation in African Americans due to leucopenia

artículo científico publicado en 2006

Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

artículo científico publicado en 2006

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice

artículo científico publicado en 2008

Comparison of clozapine use in Maryland and in Victoria, Australia

artículo científico publicado en 2005

Cortisol response to buspirone in extended abstinent alcoholics

artículo científico publicado en 2004

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

artículo científico publicado en 2009

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

scientific article published on 25 January 2011

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

artículo científico publicado en 2012

Current status of antipsychotic treatment

artículo científico publicado en 2002

Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus

artículo científico publicado en 2006

Deaths from diabetic ketoacidosis after long-term clozapine treatment

artículo científico publicado en 2003

Decisional capacity for informed consent in schizophrenia research

artículo científico publicado en 2000

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

artículo científico publicado en 2011

Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study

artículo científico publicado en 2004

Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.

artículo científico publicado en 2006

Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia

artículo científico publicado en 2008

Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis

artículo científico publicado en 2007

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra

artículo científico publicado en 2012

Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia

artículo científico publicado en 2009

Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response

artículo científico publicado en 2009

Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.

artículo científico publicado en 2007

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.

artículo científico publicado en 2010

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

artículo científico publicado en 2011

Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study

scientific article published on February 2013

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis

artículo científico publicado en 2008

Evaluating sexual function in patients with treatment-resistant schizophrenia

artículo científico publicado en 2003

Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

artículo científico publicado en 2018

Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims

artículo científico publicado en 2008

First-episode schizophrenia: a focus on pharmacological treatment and safety considerations

artículo científico publicado en 2005

Fluoxetine Augmentation of Haloperidol in Chronic Schizophrenia ⬇️

artículo científico publicado el 1 de octubre de 2003

GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide

artículo científico publicado en 2008

Galantamine for the treatment of cognitive impairments in people with schizophrenia

artículo científico publicado en 2007

Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims

artículo científico publicado en 2002

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia ⬇️

artículo científico publicado el 9 de febrero de 2011

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder ⬇️

artículo científico publicado el 3 de noviembre de 2010

Improvements in Tritrichomonas foetus molecular testing

artículo científico publicado en 2018

Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia

artículo científico publicado en 2006

Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia

artículo científico publicado en 2003

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia

artículo científico publicado en 2008

Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death

artículo científico publicado en 2004

Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects.

artículo científico publicado en 2007

Maintaining informed consent validity during lengthy research protocols.

artículo científico publicado en 2007

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials

artículo científico publicado en 2009

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine

artículo científico publicado en 2008

Mitochondria in the striatum of subjects with schizophrenia

artículo científico publicado en 2010

Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response

artículo científico publicado en 2011

Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide s

artículo científico publicado en 2010

More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk

artículo científico publicado en 2005

Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide

artículo científico publicado en 2008

Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia

artículo científico publicado en 2009

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials

artículo científico publicado en 2002

Overestimating the prevalence of subtherapeutic dosing of atypical antipsychotics

artículo científico publicado en 2009

Pathologic quiz case: a 26-year-old man with intermittent lower leg pain

artículo científico publicado en 2003

Perception of depot antipsychotics by mental health professionals.

artículo científico publicado en 2003

Pharmacogenomic associations with weight gain in olanzapine treatment of patients without schizophrenia

artículo científico publicado en 2012

Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment

scientific article published on 12 February 2020

Plasma concentrations of high-dose olanzapine in a double-blind crossover study

artículo científico publicado en 2006

Postmortem brain tissue of depressed suicides reveals increased Gs alpha localization in lipid raft domains where it is less likely to activate adenylyl cyclase.

artículo científico publicado en 2008

Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia.

artículo científico publicado en 2004

Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, co

artículo científico publicado en 2010

Prevalence of bone mineral density loss in Korean patients with schizophrenia: a cross-sectional study.

artículo científico

Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims

artículo científico publicado en 2011

Protecting confidentiality in human research

scientific article published on 01 May 2013

Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits

artículo científico publicado en 2004

Psychotropic prescribing for acute inpatient admissions in patients with severe psychosis

scientific article published on 01 February 2004

Quetiapine at high doses for the treatment of refractory schizophrenia

artículo científico publicado en 2008

Reaching for wellness in schizophrenia

artículo científico publicado en 2007

Rehospitalization risk with second-generation and depot antipsychotics

artículo científico publicado en 2003

Relationship of cerebrospinal fluid glucose metabolites to MRI deep white matter hyperintensities and treatment resistance in bipolar disorder patients

artículo científico publicado en 2008

Researcher experiences with IRBs: a survey of members of the American College of Neuropsychopharmacology

artículo científico publicado en 2011

Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms

artículo científico publicado en 2011

Rimonabant for neurocognition in schizophrenia: a 16-week double blind randomized placebo controlled trial

artículo científico publicado en 2011

Risperidone, quetiapine, and fluphenazine in the treatment of patients with therapy-refractory schizophrenia

artículo científico publicado en 2005

Second-generation antipsychotics for schizophrenia: a review of clinical pharmacology and medication-associated side effects

artículo científico publicado en 2005

Sexuality and schizophrenia: a review

artículo científico publicado en 2004

Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.

artículo científico publicado en 2003

Striatal mitochondria in subjects with chronic undifferentiated vs. chronic paranoid schizophrenia

artículo científico publicado en 2011

Suicide brain is associated with decreased expression of neurotrophins

artículo científico publicado en 2005

Synaptic differences in the patch matrix compartments of subjects with schizophrenia: a postmortem ultrastructural study of the striatum

artículo científico publicado en 2005

Synaptic differences in the postmortem striatum of subjects with schizophrenia: a stereological ultrastructural analysis

artículo científico publicado en 2005

Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia

artículo científico publicado en 2005

The Efficacy of High-Dose Olanzapine Versus Clozapine in Treatment-Resistant Schizophrenia: A Double-Blind Crossover Study ⬇️

artículo científico publicado el 1 de diciembre de 2003

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia

article

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update

artículo científico publicado en 2004

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

artículo científico publicado en 2007

The burden of depressive symptoms in people with schizophrenia

artículo científico publicado en 2009

The burden of depressive symptoms in the long-term treatment of patients with schizophrenia

artículo científico publicado en 2006

The cost of relapse and the predictors of relapse in the treatment of schizophrenia

artículo científico publicado en 2010

The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study

artículo científico publicado en 2004

The effects of galantamine on psychopathology in chronic stable schizophrenia

artículo científico publicado en 2009

The heterogeneity of schizophrenia in disease states

artículo científico publicado en 2004

The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia

artículo científico publicado en 2005

Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine

artículo científico publicado en 2005

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

scientific article published on 01 July 2019

[(3)H]cAMP binding sites and protein kinase a activity in the prefrontal cortex of suicide victims

scientific article published on 01 January 2002

mRNA and protein expression of selective alpha subunits of G proteins are abnormal in prefrontal cortex of suicide victims

artículo científico publicado en 2002

Lista de obras de

5-Lipoxygenase in the Prefrontal Cortex of Suicide Victims

A multidose study of haloperidol decanoate in the maintenance treatment of schizophrenia

A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia

A randomized double-blind trial of atomoxetine for cognitive impairments in 32 people with schizophrenia

Aberrant extracellular signal-regulated kinase (ERK) 5 signaling in hippocampus of suicide subjects

Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).

Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects

Academic highlights: guidelines for the use of long-acting injectable atypical antipsychotics

Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone

Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine

Adjunctive treatment with a dopamine partial agonist, aripiprazole, for antipsychotic-induced hyperprolactinemia: a placebo-controlled trial.

Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia

Altered expression and phosphorylation of myristoylated alanine-rich C kinase substrate (MARCKS) in postmortem brain of suicide victims with or without depression

Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects

Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis

Are we treating schizophrenia effectively? Understanding the primary outcomes of the CATIE study

Atypical antipsychotic use in a state hospital inpatient adolescent population

Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the post-mortem brain of teenage suicide victims.

Brain-derived neurotrophic factor and tyrosine kinase B receptor signalling in post-mortem brain of teenage suicide victims

Cardiovascular disease in relation to weight in deceased persons with schizophrenia

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study

Challenge to atypical antipsychotic drug effect on cognition.

Circumstances of suicide among individuals with schizophrenia

Clinical guidelines: Dosing and switching strategies for long-acting risperidone.

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

Clozapine treatment in patients with prior substance abuse

Clozapine underutilization and discontinuation in African Americans due to leucopenia

Clozapine utilization and outcomes by race in a public mental health system: 1994-2000.

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice

Comparison of clozapine use in Maryland and in Victoria, Australia

Cortisol response to buspirone in extended abstinent alcoholics

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Cost-effectiveness of olanzapine long-acting injection in the treatment of patients with schizophrenia in the United States: a micro-simulation economic decision model

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

Current status of antipsychotic treatment

Cyclic AMP response element-binding protein in post-mortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus

Deaths from diabetic ketoacidosis after long-term clozapine treatment

Decisional capacity for informed consent in schizophrenia research

Decline in hospitalization risk and health care cost after initiation of depot antipsychotics in the treatment of schizophrenia

Decreased catalytic activity and expression of protein kinase C isozymes in teenage suicide victims: a postmortem brain study

Differential and brain region-specific regulation of Rap-1 and Epac in depressed suicide victims.

Differential synaptic changes in the striatum of subjects with undifferentiated versus paranoid schizophrenia

Discontinuation of risperidone, olanzapine, and haloperidol in first-episode psychosis

Dopamine pathology in schizophrenia: analysis of total and phosphorylated tyrosine hydroxylase in the substantia nigra

Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia

Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response

Drug-drug interactions associated with second-generation antipsychotics: considerations for clinicians and patients.

Early response to antipsychotic therapy as a clinical marker of subsequent response in the treatment of patients with first-episode psychosis.

Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study

Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study

Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis

Evaluating sexual function in patients with treatment-resistant schizophrenia

Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.

Fatty acid composition of the postmortem prefrontal cortex of adolescent male and female suicide victims

First-episode schizophrenia: a focus on pharmacological treatment and safety considerations

Fluoxetine Augmentation of Haloperidol in Chronic Schizophrenia ⬇️

GSK-3beta gene expression in human postmortem brain: regional distribution, effects of age and suicide

Galantamine for the treatment of cognitive impairments in people with schizophrenia

Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims

Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophrenia ⬇️

Impact of race on efficacy and safety during treatment with olanzapine in schizophrenia, schizophreniform or schizoaffective disorder ⬇️

Improvements in Tritrichomonas foetus molecular testing

Increased expression of activity-dependent genes in cerebellar glutamatergic neurons of patients with schizophrenia

Interstitial cells of the white matter in the dorsolateral prefrontal cortex in deficit and nondeficit schizophrenia

Lack of beneficial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia

Lifetime psychiatric symptoms in persons with schizophrenia who died by suicide compared to other means of death

Lower phosphoinositide 3-kinase (PI 3-kinase) activity and differential expression levels of selective catalytic and regulatory PI 3-kinase subunit isoforms in prefrontal cortex and hippocampus of suicide subjects.

Maintaining informed consent validity during lengthy research protocols.

Maintenance of response with atypical antipsychotics in the treatment of schizophrenia: a post-hoc analysis of 5 double-blind, randomized clinical trials

Metabolic risk with second-generation antipsychotic treatment: a double-blind randomized 8-week trial of risperidone and olanzapine

Mitochondria in the striatum of subjects with schizophrenia

Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response

Modulation in activation and expression of phosphatase and tensin homolog on chromosome ten, Akt1, and 3-phosphoinositide-dependent kinase 1: further evidence demonstrating altered phosphoinositide 3-kinase signaling in postmortem brain of suicide s

More powerful two-sample tests for differences in repeated measures of adverse effects in psychiatric trials when only some patients may be at risk

Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide

Nonresponse to clozapine and premorbid functioning in treatment of refractory schizophrenia

Novel factor-based symptom scores in treatment resistant schizophrenia: implications for clinical trials